April 2024
1. FILIOGLOU D, Truscott L, Reddivalla N, Katsanis E, et al
   Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience.
   Bone Marrow Transplant. 2024 Apr 9. doi: 10.1038/s41409-024-02281.
   

   >> Share

   
   February 2024
2. GALE RP, Lazarus HM
   Is myelo-ablative pretransplant conditioning really myelo-ablative: Implications for radiation and nuclear accidents?
   Bone Marrow Transplant. 2024;59:159-161.
   

   >> Share

   
   December 2023
3. MEYERS G, Hamadani M, Martens M, Ali H, et al
   Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
   Bone Marrow Transplant. 2023;58:1416-1418.
   

   >> Share

   
   November 2023
4. CAO LQ, Huo WX, Zhang XH, Xu LP, et al
   Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients.
   Bone Marrow Transplant. 2023 Nov 15. doi: 10.1038/s41409-023-02117.
   

   >> Share

   
   
5. FUJI S, Hakoda A, Kanda J, Fukuda T, et al
   Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy.
   Bone Marrow Transplant. 2023;58:1257-1259.
   

   >> Share

   
   October 2023
6. SHIMOMURA Y, Komukai S, Kitamura T, Sobue T, et al
   Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.
   Bone Marrow Transplant. 2023 Oct 28. doi: 10.1038/s41409-023-02142.
   

   >> Share

   
   September 2023
7. HONG J, Fraebel J, Yang Y, Tkacyk E, et al
   Understanding and treatment of cutaneous graft-versus-host-disease.
   Bone Marrow Transplant. 2023 Sep 20. doi: 10.1038/s41409-023-02109.
   

   >> Share

   
   
8. WOREL N, Ljungman P, Verheggen ICM, Hoogenboom JD, et al
   Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Pa
   Bone Marrow Transplant. 2023 Sep 6. doi: 10.1038/s41409-023-02099.
   

   >> Share

   
   August 2023
9. RAGHUNANDAN S, Gorfinkel L, Bratrude B, Suessmuth Y, et al
   Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
   Bone Marrow Transplant. 2023 Aug 14. doi: 10.1038/s41409-023-02034.
   

   >> Share

   
   July 2023
10. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.
    Bone Marrow Transplant. 2023;58:832-834.
    

    >> Share

    
    June 2023
11. DE WITTE MA, Mooyaart JE, Hoogenboom JD, Chabannon C, et al
    Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party.
    Bone Marrow Transplant. 2023;58:719-722.
    

    >> Share

    
    March 2023
12. MOISEEV I, Ambron P, Badoglio M, Peczynski C, et al
    Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2023;58:325-327.
    

    >> Share

    
    January 2023
13. KATSUYA H, Yamaguchi K, Dung TC, Sano H, et al
    Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia.
    Bone Marrow Transplant. 2023 Jan 21. doi: 10.1038/s41409-023-01923.
    

    >> Share

    
    
14. SROUR M, Alsuliman T, Labreuche J, Bulabois CE, et al
    Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of
    Bone Marrow Transplant. 2023 Jan 9. doi: 10.1038/s41409-022-01898.
    

    >> Share

    
    
15. WANG M, Guo W, Zheng X, Wang J, et al
    Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning.
    Bone Marrow Transplant. 2023;58:94-96.
    

    >> Share

    
    November 2022
16. MOISEEV I, Barabanshikova M, Dotsenko A, Smirnova A, et al
    First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens.
    Bone Marrow Transplant. 2022 Nov 30. doi: 10.1038/s41409-022-01879.
    

    >> Share

    
    
17. CHU M, Hu S, Shen Y, Shen D, et al
    Comparison of clinical outcomes between peripheral blood stem cells and peripheral blood stem cells plus bone marrow in myelodysplastic syndrome patients with haploidentical transplantation.
    Bone Marrow Transplant. 2022 Nov 5. pii: 10.1038/s41409-022-01862.
    

    >> Share

    
    
18. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group - Poster Session (P607-P610).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
19. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group - Oral Session (O159-O162).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
20. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group - Poster Session (P601- P606).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
21. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee - Oral Session (O156-O158).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
22. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group - Poster Sessions (NP001 - NP054).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
23. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group - Oral Session (NO001 - NO006).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
24. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O155).
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
25. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Reviewers.
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
26. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards.
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
27. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Lectures.
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
28. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising Committee.
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    
29. 
    The 48(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Welcome Address.
    Bone Marrow Transplant. 2022;57.
    

    >> Share

    
    September 2022
30. ATSUTA Y, Sugita J, Nakamae H, Maruyama Y, et al
    Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2022 Sep 12. pii: 10.1038/s41409-022-01822.
    

    >> Share

    
    
31. DE WREEDE LC, Schetelig J, Putter H
    Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions.
    Bone Marrow Transplant. 2022;57:1428-1434.
    

    >> Share

    
    August 2022
32. ELLIOTT J, Ahlawat S, Prince HM, Kennedy G, et al
    Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides.
    Bone Marrow Transplant. 2022 Aug 26. pii: 10.1038/s41409-022-01787.
    

    >> Share

    
    
33. GURNARI C, McLornan DP
    Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
    Bone Marrow Transplant. 2022 Aug 8. pii: 10.1038/s41409-022-01774.
    

    >> Share

    
    July 2022
34. JACOBS JW, Adkins BD, Wheeler AP, Booth GS, et al
    Diversity, equity, and inclusion in transfusion medicine, blood donation, and blood and bone marrow transplantation: language matters.
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01758.
    

    >> Share

    
    
35. XU LP, Xu ZL, Zhang YY, Cheng YF, et al
    Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia.
    Bone Marrow Transplant. 2022;57:1204-1206.
    

    >> Share

    
    June 2022
36. LE BRIS Y, Costes D, Bourgade R, Guillaume T, et al
    Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies.
    Bone Marrow Transplant. 2022 Jun 28. pii: 10.1038/s41409-022-01747.
    

    >> Share

    
    
37. TANG L, Wu Y, Lei R, Liu J, et al
    Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes.
    Bone Marrow Transplant. 2022 Jun 22. pii: 10.1038/s41409-022-01729.
    

    >> Share

    
    
38. WEI B
    Quantile regression for censored data in haematopoietic cell transplant research.
    Bone Marrow Transplant. 2022;57:853-856.
    

    >> Share

    
    May 2022
39. DUQUE-AFONSO J, Finke J, Labopin M, Craddock C, et al
    Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2022 May 14. pii: 10.1038/s41409-022-01646.
    

    >> Share

    
    
40. WADA F, Kondo T, Yamamoto R, Yamagiwa T, et al
    Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2022 May 2. pii: 10.1038/s41409-022-01692.
    

    >> Share

    
    March 2022
41. MITRUS I, Wilkiewicz M, Fidyk W, Ciomber A, et al
    The impact of blood donation on bone marrow harvest efficiency.
    Bone Marrow Transplant. 2022;57:507-509.
    

    >> Share

    
    February 2022
42. CRUZ CRY, Bo N, Bakoyannis G, Wright KE, et al
    Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort.
    Bone Marrow Transplant. 2022;57:279-281.
    

    >> Share

    
    January 2022
43. KAWAJIRI A, Kawase T, Tanaka H, Fukuda T, et al
    Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation.
    Bone Marrow Transplant. 2022 Jan 21. pii: 10.1038/s41409-021-01552.
    

    >> Share

    
    October 2021
44. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    

    >> Share

    
    
45. RAFII H, Ionescu I, Ruggeri A, Garnier F, et al
    Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC).
    Bone Marrow Transplant. 2021 Oct 7. pii: 10.1038/s41409-021-01477.
    

    >> Share

    
    September 2021
46. RAMOS TL, Garcia-Guerrero E, Caballero-Velazquez T, Rodriguez-Gil A, et al
    Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Sep 23. pii: 10.1038/s41409-021-01452.
    

    >> Share

    
    August 2021
47. BALDONI S, Ruggeri L, Del Papa B, Sorcini D, et al
    NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models.
    Bone Marrow Transplant. 2021;56:2019-2023.
    

    >> Share

    
    July 2021
48. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    

    >> Share

    
    
49. SOCIE G, Peffault de Latour R
    Secondary malignancies after transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01400.
    

    >> Share

    
    June 2021
50. HABERMANN S, Ferran E, Hatcher J, Lyall H, et al
    Outbreak of non-tuberculous mycobacteria in a paediatric bone marrow transplant unit associated with water contamination of needle-free connectors and literature review.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01239.
    

    >> Share

    
    May 2021
51. IFTIKHAR R, Ahmad P, de Latour R, Dufour C, et al
    Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia workin
    Bone Marrow Transplant. 2021 May 19. pii: 10.1038/s41409-021-01332.
    

    >> Share

    
    
52. RAFII H, Garnier F, Ruggeri A, Ionescu I, et al
    Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC).
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01313.
    

    >> Share

    
    
53. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    

    >> Share

    
    April 2021
54. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    

    >> Share

    
    
55. SPITZER TR, Kim SE, Cohen R, Mathews R, et al
    Declining bone marrow harvest quality over 24 years: a single institution experience.
    Bone Marrow Transplant. 2021;56:983-985.
    

    >> Share

    
    March 2021
56. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    

    >> Share

    
    
57. FAULKNER L, Verna M, Rovelli A, Agarwal RK, et al
    Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP.
    Bone Marrow Transplant. 2021;56:536-543.
    

    >> Share

    
    
58. KAGEYAMA K, Uchida N, Yamamoto H, Takagi S, et al
    HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC.
    Bone Marrow Transplant. 2021;56:686-688.
    

    >> Share

    
    February 2021
59. UEDA OSHIMA M, Sandmaier BM, Petersdorf E, Flowers ME, et al
    Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach.
    Bone Marrow Transplant. 2021;56:305-313.
    

    >> Share

    
    January 2021
60. BALDUZZI A, Bonig H, Jarisch A, Nava T, et al
    ABO incompatibile graft management in pediatric transplantation.
    Bone Marrow Transplant. 2021;56:84-90.
    

    >> Share

    
    December 2020
61. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    

    >> Share

    
    July 2020
62. CIUREA SO, Kongtim P, Srour S, Saini N, et al
    Can we cure refractory Hodgkin's lymphoma with transplantation?
    Bone Marrow Transplant. 2020 Jul 7. pii: 10.1038/s41409-020-0989.
    

    >> Share

    
    
63. SHIRATORI S, Sugita J, Ota S, Kasahara S, et al
    Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 5. pii: 10.1038/s41409-020-0985.
    

    >> Share

    
    November 2019
64. TAPPENDEN P, Wang Y, Sharrack B, Burman J, et al
    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Workin
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0747.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share